Search Within

James Joseph Harding

Formats
  1. Meeting Abstract (124)
  2. Journal Article (116)
  3. Review (7)
  4. Book Section (3)
  5. Miscellaneous (3)
Groups
  1. Department of Medicine (253)
  2. Gastrointestinal Oncology Service (253)
  3. Solid Tumor Oncology Division (253)
  4. Center for Pancreatic Cancer Research (130)
  5. GSK Faculty (99)
  6. Epidemiology and Biostatistics (89)

More Groups

People
  1. Ghassan Abou-Alfa (130)
  2. Eileen O'Reilly (70)
  3. William Jarnagin (59)
  4. Michael D'Angelica (40)
  5. Andrea Cercek Hanjis (38)
  6. Michael Berger (37)

More People

Years
  1. 2025 (14)
  2. 2024 (32)
  3. 2023 (34)
  4. 2022 (21)
  5. 2021 (23)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (88)
  2. Annals of Oncology (17)
  3. Clinical Cancer Research (15)
  4. Annals of Surgical Oncology (13)
  5. Cancer (9)
  6. JCO Precision Oncology (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (99)
  2. Oxford University Press (25)
  3. American Association for Cancer Research (23)
  4. Springer (21)
  5. Wiley Blackwell (14)
  6. Elsevier Science, Inc. (10)

More Publishers

Results (253)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Second-line chemotherapy (CTx) outcomes in advanced biliary cancers (ABC): A retrospective multicenter analysis
    Meeting Abstract

    Lowery, M. A.; Goff, L. W.; Jordan, E.; Wang, R.; Bocobo, A. G.; Chou, J. F.; O'Reilly, E. M.; Harding, J. J.; Kemeny, N. E.; Capanu, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Emibetuzumab plus ramucirumab: Simultaneous targeting of MET and VEGFR-2 in patients with advanced hepatocellular cancer in a phase 1b/2 study
    Meeting Abstract

    Harding, J. J.; Bendell, J. C.; Fuchs, C. S.; Wang, X. J.; Wacheck, V.; Zhu, A. X.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Advanced hepatocellular cancer: The current state of future research
    Journal Article

    Connell, L. C.; Harding, J. J.; Abou-Alfa, G. K.
    Current Treatment Options in Oncology (2016)

    Fulltext@MSK | Save
  • Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
    Journal Article

    Harding, J. J.; El Dika, I.; Abou-Alfa, G. K.
    Cancer (2016)

    Fulltext@MSK | Save
  • A phase I trial of binimetinib in combination with gemcitabine (G) and cisplatin (C) patients (pts) with untreated advanced biliary cancer (ABC)
    Meeting Abstract

    Lowery, M. A.; O'Reilly, E. M.; Harding, J. J.; Salehi, E.; Hollywood, E.; Bradley, M.; Sophos, N. A.; Ly, M.; Capanu, M.; Gerst, S. R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Hepatocellular carcinoma (HCC) and bone metastases (Mets)
    Meeting Abstract

    Harding, J. J.; Abu Zeinah, G.; Chou, J. F.; Owen, D. H.; Ly, M.; Lowery, M. A.; O'Reilly, E. M.; Capanu, M.; Saltz, L.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Safety and tolerability of increasing doses of CB-839, a first-in-class, orally administered small molecule inhibitor of glutaminase, in solid tumors
    Meeting Abstract

    Harding, J. J.; Telli, M. L.; Munster, P. N.; Le, M. H.; Molineaux, C.; Bennett, M. K.; Mittra, E.; Burris, H. A.; Clark, A. S.; Dunphy, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of the HSP-90 inhibitor PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phenotypic correlation of tumor uptake of exogenous glutamine radiotracer versus tumor mutational status
    Meeting Abstract

    Dunphy, M.; Harding, J. J.; Lewis, J. S.; Mellinghoff, I. K.; Omuro, A. M. P.; Hsieh, J.; Zhang, H. W.; Zanzonico, P.; Venneti, S.; Carlin, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Platinum-based combination therapy (PCT) and outcomes for patients (pts) with mixed hepatocellular carcinoma and intrahepatic cholangiocarcinoma (mHCC/ICC)
    Meeting Abstract

    Connell, L. C.; Harding, J. J.; Lowery, M. A.; Kemeny, N. E.; Cercek, A.; Abdelgawad, M. I.; O'Reilly, E. M.; Saltz, L.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save